UnitedHealth Beats Q3 Estimates and Raises Full-Year Profit Outlook as Medical Costs Come In Below Forecast

UnitedHealth Group reported third-quarter adjusted earnings per share of $4.69 on October 13, surpassing the $4.12 consensus estimate by $0.57 and marking a 61% jump from the year-earlier period. Revenue came in at $112.69 billion, ahead of the $111.03 billion estimate and roughly flat year over year. GAAP net income rose to $4.11 billion, or $4.56 per share, from $2.35 billion, or $2.59 per share, a year earlier, while earnings from operations climbed 52% to $6.6 billion.

The standout result was the medical care ratio, which fell to 88.4% against an estimate of roughly 90%, reflecting tighter cost controls across both the UnitedHealthcare insurance segment and the Optum clinical and technology units. The operating cost ratio also improved, dropping to 12.8% from 13.5% a year earlier. A $610 million net favorable prior-period reserve development contributed to the MCR improvement. Optum generated $3.7 billion in segment earnings, while UnitedHealthcare posted $2.8 billion. Total people served by UnitedHealthcare stood at 48.3 million, slightly below the 48.62 million estimate.

On the strength of the quarter, UnitedHealth raised its full-year 2026 adjusted EPS guidance to at least $20.50, up from a prior range of $19.50 to $20.00 and above the $19.86 analyst consensus. The GAAP EPS outlook was raised to at least $19.50 from a prior range of $18.45 to $18.95. The company has repurchased $5.0 billion in shares and paid $6.2 billion in dividends year to date through September 30. Operating cash flow for the quarter was $5.1 billion.

Shares jumped more than 3% in premarket trading and gained roughly 5% by some reports after the open, with Dow futures rising about 0.78% on the healthcare-driven lift. Analysts flagged the earnings call as an opportunity to gauge commentary on 2027 growth, with Benzinga noting that Wall Street may be underestimating the company's 2027 earnings potential. Mizuho reiterated its rating on the stock following the results.